Protein linked to high risk of Alzheimer's can be removed from brain without hindering learning

October 4, 2016
brain
White matter fiber architecture of the brain. Credit: Human Connectome Project.

A protein linked to higher risk of Alzheimer's can be removed from the brains of mice without hindering memory and learning, according to a study that addresses whether potential therapeutics targeting this protein would have detrimental side effects.

The study from the Peter O'Donnell Jr. Brain Institute also showed, however, that the protein's absence in other parts of the body hinders brain function as rise. This result substantiates previous research that indicated cardiovascular health affects the brain.

Researchers focused on the removal of apolipoprotein E (ApoE), which in a certain form can support the buildup of toxic plaques in the brains of Alzheimer's patients. Studies elsewhere have sought to determine whether reducing ApoE could be an effective treatment in preventing the disease, but a lingering question has been whether the protein is necessary for healthy brain function.

The study found that mice can maintain their learning and memory when virtually all ApoE is removed from the brain but kept present in the liver to filter cholesterol. Mice that lacked ApoE in both the brain and liver experienced unhealthy and lost cognitive function.

More research is needed to determine what causes the cardiovascular issues to affect the brain, said Dr. Joachim Herz, the study's Principal Investigator and Professor of Molecular Genetics, Neuroscience, Neurology and Neurotherapeutics at the O'Donnell Brain Institute at UT Southwestern Medical Center.

But the findings, published in The Journal of Neuroscience, add support to the belief that reducing ApoE in the brain could eventually be a viable therapeutic option for treating Alzheimer's.

"This approach still holds potential," said Dr. Herz, holder of the Thomas O. and Cinda Hicks Family Distinguished Chair in Alzheimer's Disease Research and Director of the Center for Translational Neurodegeneration Research.

ApoE has several roles in the body, including transporting cholesterol and related molecules such as β-amyloid that form plaques in the brains of Alzheimer's patients if not properly filtered or removed.

The type of ApoE produced by the ApoE gene determines how effectively the amyloid is removed from the brain. ApoE2 is the most effective, ApoE3 is in the middle and ApoE4 is the most likely to allow for the buildup of amyloid plaques. People whose genes produce ApoE4 are at high risk of developing Alzheimer's.

Studies are ongoing at UT Southwestern and elsewhere to further understand the various effects that ApoE4 removal has on and body function.

Explore further: Scientists reveal why people with the ApoE4 gene are more susceptible to Alzheimer's disease

Related Stories

Scientists reveal why people with the ApoE4 gene are more susceptible to Alzheimer's disease

August 17, 2016
For decades, scientists have known that people with two copies of a gene called apolipoprotein E4 (ApoE4) are much more likely to have Alzheimer's disease at age 65 than the rest of the population. Now, researchers at the ...

Normal cognition in patient without apolipoprotein E, risk factor for Alzheimer's

August 11, 2014
A 40-year-old California man exhibits normal cognitive function although he has no apolipoprotein E (apoE), which is believed to be important for brain function but a mutation of which is also a known risk factor for Alzheimer ...

An anti-apoE4 specific monoclonal antibody counteracts the pathological effects of apoE4 in vivo

June 30, 2016
The pathological hallmarks of Alzheimer's disease (AD), viz defective Aβ and tau proteins, have been the center of AD-directed therapeutic studies. Although this approach still remains valid, it has not yet produced clinically ...

Malfunctioning protein a cause of Alzheimer's plaques

June 30, 2011
(Medical Xpress) -- In a new study published in Science Translational Medicine, scientists from the Washington University School of Medicine in St Louis reveal their discovery of a protein made by an Alzheimer’s gene ...

Possible biological function for the Alzheimer protein amyloid-beta

November 4, 2015
A new study from Karolinska Institutet shows that amyloid-β-peptides, which are thought to be toxic and a suspected cause of Alzheimer's disease, actually have a biological function. The discovery, which is published in ...

Recommended for you

Study shows video games could cut dementia risk in seniors

November 16, 2017
Could playing video games help keep the brain agile as we age?

New player in Alzheimer's disease pathogenesis identified

November 14, 2017
Scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) have shown that a protein called membralin is critical for keeping Alzheimer's disease pathology in check. The study, published in Nature Communications, ...

Biomarker may predict early Alzheimer's disease

November 10, 2017
Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a peptide that could lead to the early detection of Alzheimer's disease (AD). The discovery, published in Nature Communications, may ...

Smell test challenge suggests clinical benefit for some before development of Alzheimer's

November 10, 2017
Researchers at Columbia University Medical Center (CUMC) and the New York State Psychiatric Institute (NYSPI) may have discovered a way to use a patient's sense of smell to treat Alzheimer's disease before it ever develops. ...

How SORLA protects against Alzheimer's disease

November 7, 2017
Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a new protective function for a brain protein genetically linked to Alzheimer's. The findings, published in the Journal of Experimental ...

Saving neurons may offer new approach for treating Alzheimer's disease

November 6, 2017
Treatment with a neuroprotective compound that saves brain cells from dying also prevents the development of depression-like behavior and the later onset of memory and learning problems in a rat model of Alzheimer's disease. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.